Logo image of ENX.PA

EURONEXT NV (ENX.PA) Stock Fundamental Analysis

Europe - EPA:ENX - NL0006294274 - Common Stock

138.45 EUR
+0.85 (+0.62%)
Last: 9/12/2025, 4:56:14 PM
Fundamental Rating

5

Overall ENX gets a fundamental rating of 5 out of 10. We evaluated ENX against 109 industry peers in the Capital Markets industry. While ENX has a great profitability rating, there are some minor concerns on its financial health. ENX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ENX was profitable.
ENX had a positive operating cash flow in the past year.
Each year in the past 5 years ENX has been profitable.
In the past 5 years ENX always reported a positive cash flow from operatings.
ENX.PA Yearly Net Income VS EBIT VS OCF VS FCFENX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

ENX has a Return On Assets (0.35%) which is in line with its industry peers.
ENX's Return On Equity of 23.01% is amongst the best of the industry. ENX outperforms 88.07% of its industry peers.
ENX has a better Return On Invested Capital (13.31%) than 91.74% of its industry peers.
ENX had an Average Return On Invested Capital over the past 3 years of 6.82%. This is in line with the industry average of 8.66%.
The 3 year average ROIC (6.82%) for ENX is below the current ROIC(13.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.35%
ROE 23.01%
ROIC 13.31%
ROA(3y)0.24%
ROA(5y)2.39%
ROE(3y)12.67%
ROE(5y)15.83%
ROIC(3y)6.82%
ROIC(5y)8.05%
ENX.PA Yearly ROA, ROE, ROICENX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 37.70%, ENX belongs to the top of the industry, outperforming 80.73% of the companies in the same industry.
ENX's Profit Margin has improved in the last couple of years.
The Operating Margin of ENX (51.60%) is better than 88.07% of its industry peers.
In the last couple of years the Operating Margin of ENX has remained more or less at the same level.
Industry RankSector Rank
OM 51.6%
PM (TTM) 37.7%
GM N/A
OM growth 3Y1.34%
OM growth 5Y-0.82%
PM growth 3Y4.18%
PM growth 5Y1.95%
GM growth 3YN/A
GM growth 5YN/A
ENX.PA Yearly Profit, Operating, Gross MarginsENX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, ENX has less shares outstanding
The number of shares outstanding for ENX has been increased compared to 5 years ago.
The debt/assets ratio for ENX has been reduced compared to a year ago.
ENX.PA Yearly Shares OutstandingENX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENX.PA Yearly Total Debt VS Total AssetsENX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

ENX has an Altman-Z score of 0.07. This is a bad value and indicates that ENX is not financially healthy and even has some risk of bankruptcy.
ENX's Altman-Z score of 0.07 is in line compared to the rest of the industry. ENX outperforms 45.87% of its industry peers.
ENX has a debt to FCF ratio of 5.20. This is a neutral value as ENX would need 5.20 years to pay back of all of its debts.
ENX has a better Debt to FCF ratio (5.20) than 71.56% of its industry peers.
ENX has a Debt/Equity ratio of 0.61. This is a neutral value indicating ENX is somewhat dependend on debt financing.
ENX's Debt to Equity ratio of 0.61 is in line compared to the rest of the industry. ENX outperforms 55.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.2
Altman-Z 0.07
ROIC/WACCN/A
WACCN/A
ENX.PA Yearly LT Debt VS Equity VS FCFENX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

ENX has a Current Ratio of 1.00. This is a normal value and indicates that ENX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ENX (1.00) is better than 63.30% of its industry peers.
A Quick Ratio of 1.00 indicates that ENX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, ENX is in the better half of the industry, outperforming 63.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
ENX.PA Yearly Current Assets VS Current LiabilitesENX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.14% over the past year.
Measured over the past years, ENX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.67% on average per year.
ENX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.09%.
The Revenue has been growing by 19.09% on average over the past years. This is quite good.
EPS 1Y (TTM)21.14%
EPS 3Y7.11%
EPS 5Y17.67%
EPS Q2Q%27.04%
Revenue 1Y (TTM)-15.09%
Revenue growth 3Y7.8%
Revenue growth 5Y19.09%
Sales Q2Q%12.81%

3.2 Future

Based on estimates for the next years, ENX will show a small growth in Earnings Per Share. The EPS will grow by 2.58% on average per year.
ENX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.35% yearly.
EPS Next Y10.46%
EPS Next 2Y8.68%
EPS Next 3Y8.34%
EPS Next 5Y2.58%
Revenue Next Year11.99%
Revenue Next 2Y8.73%
Revenue Next 3Y7.6%
Revenue Next 5Y4.35%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ENX.PA Yearly Revenue VS EstimatesENX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
ENX.PA Yearly EPS VS EstimatesENX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

ENX is valuated rather expensively with a Price/Earnings ratio of 19.18.
Based on the Price/Earnings ratio, ENX is valued a bit cheaper than the industry average as 64.22% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.43. ENX is valued slightly cheaper when compared to this.
ENX is valuated rather expensively with a Price/Forward Earnings ratio of 17.84.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ENX indicates a somewhat cheap valuation: ENX is cheaper than 71.56% of the companies listed in the same industry.
ENX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.18
Fwd PE 17.84
ENX.PA Price Earnings VS Forward Price EarningsENX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ENX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ENX is cheaper than 77.06% of the companies in the same industry.
ENX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ENX is cheaper than 75.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.09
EV/EBITDA 10.23
ENX.PA Per share dataENX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ENX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of ENX may justify a higher PE ratio.
PEG (NY)1.83
PEG (5Y)1.09
EPS Next 2Y8.68%
EPS Next 3Y8.34%

4

5. Dividend

5.1 Amount

ENX has a Yearly Dividend Yield of 2.07%.
ENX's Dividend Yield is comparable with the industry average which is at 6.20.
Compared to an average S&P500 Dividend Yield of 2.45, ENX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.07%

5.2 History

On average, the dividend of ENX grows each year by 11.82%, which is quite nice.
Dividend Growth(5Y)11.82%
Div Incr Years4
Div Non Decr Years4
ENX.PA Yearly Dividends per shareENX.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

ENX pays out 30.03% of its income as dividend. This is a sustainable payout ratio.
ENX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.03%
EPS Next 2Y8.68%
EPS Next 3Y8.34%
ENX.PA Yearly Income VS Free CF VS DividendENX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ENX.PA Dividend Payout.ENX.PA Dividend Payout, showing the Payout Ratio.ENX.PA Dividend Payout.PayoutRetained Earnings

EURONEXT NV

EPA:ENX (9/12/2025, 4:56:14 PM)

138.45

+0.85 (+0.62%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-06 2025-11-06
Inst Owners52.44%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap14.43B
Analysts73.33
Price Target156.25 (12.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.07%
Yearly Dividend2.46
Dividend Growth(5Y)11.82%
DP30.03%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.03%
Min EPS beat(2)1.27%
Max EPS beat(2)4.79%
EPS beat(4)4
Avg EPS beat(4)4.32%
Min EPS beat(4)1.27%
Max EPS beat(4)6.1%
EPS beat(8)8
Avg EPS beat(8)5.32%
EPS beat(12)11
Avg EPS beat(12)5.55%
EPS beat(16)14
Avg EPS beat(16)5.25%
Revenue beat(2)2
Avg Revenue beat(2)0.5%
Min Revenue beat(2)0.31%
Max Revenue beat(2)0.69%
Revenue beat(4)3
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)1.05%
Revenue beat(8)5
Avg Revenue beat(8)0.03%
Revenue beat(12)7
Avg Revenue beat(12)6.46%
Revenue beat(16)10
Avg Revenue beat(16)17.34%
PT rev (1m)1.28%
PT rev (3m)15.16%
EPS NQ rev (1m)-1.77%
EPS NQ rev (3m)-1.82%
EPS NY rev (1m)4.21%
EPS NY rev (3m)4.21%
Revenue NQ rev (1m)0.49%
Revenue NQ rev (3m)8.45%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)3.86%
Valuation
Industry RankSector Rank
PE 19.18
Fwd PE 17.84
P/S 5.57
P/FCF 24.09
P/OCF 19.55
P/B 3.4
P/tB N/A
EV/EBITDA 10.23
EPS(TTM)7.22
EY5.21%
EPS(NY)7.76
Fwd EY5.6%
FCF(TTM)5.75
FCFY4.15%
OCF(TTM)7.08
OCFY5.11%
SpS24.86
BVpS40.73
TBVpS-17.76
PEG (NY)1.83
PEG (5Y)1.09
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 23.01%
ROCE 17.66%
ROIC 13.31%
ROICexc 17.27%
ROICexgc N/A
OM 51.6%
PM (TTM) 37.7%
GM N/A
FCFM 23.12%
ROA(3y)0.24%
ROA(5y)2.39%
ROE(3y)12.67%
ROE(5y)15.83%
ROIC(3y)6.82%
ROIC(5y)8.05%
ROICexc(3y)8.95%
ROICexc(5y)12.69%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.05%
ROCE(5y)10.68%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y9.06%
ROICexc growth 5Y-11.21%
OM growth 3Y1.34%
OM growth 5Y-0.82%
PM growth 3Y4.18%
PM growth 5Y1.95%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.2
Debt/EBITDA 1.69
Cap/Depr 71.93%
Cap/Sales 5.37%
Interest Coverage 43.15
Cash Conversion 48.23%
Profit Quality 61.31%
Current Ratio 1
Quick Ratio 1
Altman-Z 0.07
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)56.3%
Cap/Depr(5y)51.18%
Cap/Sales(3y)6.45%
Cap/Sales(5y)5.35%
Profit Quality(3y)121.66%
Profit Quality(5y)112.44%
High Growth Momentum
Growth
EPS 1Y (TTM)21.14%
EPS 3Y7.11%
EPS 5Y17.67%
EPS Q2Q%27.04%
EPS Next Y10.46%
EPS Next 2Y8.68%
EPS Next 3Y8.34%
EPS Next 5Y2.58%
Revenue 1Y (TTM)-15.09%
Revenue growth 3Y7.8%
Revenue growth 5Y19.09%
Sales Q2Q%12.81%
Revenue Next Year11.99%
Revenue Next 2Y8.73%
Revenue Next 3Y7.6%
Revenue Next 5Y4.35%
EBIT growth 1Y-4.2%
EBIT growth 3Y9.25%
EBIT growth 5Y18.11%
EBIT Next Year25.83%
EBIT Next 3Y11.99%
EBIT Next 5Y7.1%
FCF growth 1Y14.67%
FCF growth 3Y9.28%
FCF growth 5Y22.23%
OCF growth 1Y17.49%
OCF growth 3Y9.23%
OCF growth 5Y22.8%